 | | A1ADY | | Name: | (2~{S})-2-azanyl-3-[2-[oxidanyl(oxidanylidene)-$l^{4}-azanyl]phenyl]propan-1-ol | | Formula: | C9 H10 N2 O4 | | SMILES: | O=[N+]([O-])c1ccccc1CC(N)C(=O)O | | InChi: | InChI=1S/C9H10N2O4/c10-7(9(12)13)5-6-3-1-2-4-8(6)11(14)15/h1-4,7H,5,10H2,(H,12,13)/t7-/m0/s1 | | Definition date: | 2024-01-29 | | Last modified: | 2024-03-08 | | Release date: | 2024-03-13 | | Identifier: | 2-nitro-L-phenylalanine |
|
 | | A1ADZ | | Name: | (2S)-2-amino-3-(2-methoxyphenyl)propan-1-ol | | Formula: | C10 H13 N O3 | | SMILES: | COc1ccccc1CC(N)C(=O)O | | InChi: | InChI=1S/C10H13NO3/c1-14-9-5-3-2-4-7(9)6-8(11)10(12)13/h2-5,8H,6,11H2,1H3,(H,12,13)/t8-/m0/s1 | | Definition date: | 2024-01-29 | | Last modified: | 2024-03-08 | | Release date: | 2024-03-13 | | Identifier: | 2-methoxy-L-phenylalanine |
|
 | | MIQ | | Name: | 2-[(3S)-2,6-dioxopiperidin-3-yl]-5-(morpholin-4-yl)-1H-isoindole-1,3(2H)-dione | | Formula: | C17 H17 N3 O5 | | SMILES: | O=C1NC(=O)CCC1N1C(=O)c2cc(ccc2C1=O)N1CCOCC1 | | InChi: | InChI=1S/C17H17N3O5/c21-14-4-3-13(15(22)18-14)20-16(23)11-2-1-10(9-12(11)17(20)24)19-5-7-25-8-6-19/h1-2,9,13H,3-8H2,(H,18,21,22)/t13-/m0/s1 | | Definition date: | 2023-08-15 | | Last modified: | 2024-03-08 | | Release date: | 2024-03-13 | | Identifier: | 2-[(3S)-2,6-dioxopiperidin-3-yl]-5-(morpholin-4-yl)-1H-isoindole-1,3(2H)-dione |
|
 | | QW8 | | Name: | naphthalene-1,3,6,8-tetrol | | Formula: | C10 H8 O4 | | SMILES: | Oc1cc(O)c2c(O)cc(O)cc2c1 | | InChi: | InChI=1S/C10H8O4/c11-6-1-5-2-7(12)4-9(14)10(5)8(13)3-6/h1-4,11-14H | | Synonyms: | 1,3,6,8-tetrahydroxynaphthalene | | Definition date: | 2023-08-30 | | Last modified: | 2024-03-08 | | Release date: | 2024-03-13 | | Identifier: | naphthalene-1,3,6,8-tetrol |
|
 | | 9YP | | Name: | {[(2R)-2-[(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methyl]-3-(2-phosphonoethoxy)propoxy]methyl}phosphonic acid | | Formula: | C12 H21 N5 O9 P2 | | SMILES: | O=P(O)(O)CCOCC(COCP(=O)(O)O)Cn1cnc2c1N=C(N)NC2=O | | InChi: | InChI=1S/C12H21N5O9P2/c13-12-15-10-9(11(18)16-12)14-6-17(10)3-8(5-26-7-28(22,23)24)4-25-1-2-27(19,20)21/h6,8H,1-5,7H2,(H2,19,20,21)(H2,22,23,24)(H3,13,15,16,18)/t8-/m1/s1 | | Definition date: | 2017-06-27 | | Last modified: | 2024-03-02 | | Release date: | 2017-08-30 | | Identifier: | {[(2R)-2-[(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methyl]-3-(2-phosphonoethoxy)propoxy]methyl}phosphonic acid |
|
 | | YIJ | | Name: | (1R)-1-[(5aR,7aR,9R,11aS,11bS,12R,13aR)-9,12-dihydroxy-2,11a-dimethyl-1,2,3,4,7a,8,9,10,11,11a,12,13-dodecahydro-7H-9,11b-epoxy-13a,5a-prop[1]enophenanthro[2,1-f][1,4]oxazepin-14-yl]ethyl benzoate | | Formula: | C31 H39 N O6 | | SMILES: | CC(OC(=O)c1ccccc1)C1=CCC23OCCN(C)CC13CC(O)C13OC4(O)CC(CC=C12)C3(C)CC4 | | InChi: | InChI=1S/C31H39NO6/c1-20(37-26(34)21-7-5-4-6-8-21)23-11-12-30-24-10-9-22-17-29(35)14-13-27(22,2)31(24,38-29)25(33)18-28(23,30)19-32(3)15-16-36-30/h4-8,10-11,20,22,25,33,35H,9,12-19H2,1-3H3/t20-,22-,25-,27+,28+,29-,30+,31+/m1/s1 | | Definition date: | 2023-06-19 | | Last modified: | 2024-03-01 | | Release date: | 2024-03-06 | | Identifier: | (1R)-1-[(5aR,7aR,9R,11aS,11bS,12R,13aR)-9,12-dihydroxy-2,11a-dimethyl-1,2,3,4,7a,8,9,10,11,11a,12,13-dodecahydro-7H-9,11b-epoxy-13a,5a-prop[1]enophenanthro[2,1-f][1,4]oxazepin-14-yl]ethyl benzoate |
|
 | | XJR | | Name: | N-(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)-2-(4-methoxyphenoxy)acetamide | | Formula: | C20 H21 N3 O4 | | SMILES: | COc1ccc(OCC(=O)NC2=C(C)N(C)N(C2=O)c3ccccc3)cc1 | | InChi: | InChI=1S/C20H21N3O4/c1-14-19(20(25)23(22(14)2)15-7-5-4-6-8-15)21-18(24)13-27-17-11-9-16(26-3)10-12-17/h4-12H,13H2,1-3H3,(H,21,24) | | Synonyms: | N-(1,5-dimethyl-3-oxidanylidene-2-phenyl-pyrazol-4-yl)-2-(4-methoxyphenoxy)ethanamide | | Definition date: | 2023-11-03 | | Last modified: | 2024-03-01 | | Release date: | 2024-03-06 | | Identifier: | ~{N}-(1,5-dimethyl-3-oxidanylidene-2-phenyl-pyrazol-4-yl)-2-(4-methoxyphenoxy)ethanamide |
|
 | | XKQ | | Name: | methyl {(2S)-1-[(1S,3aR,6aS)-1-{[(2R,3S)-6,6-difluoro-2-hydroxy-1-(methylamino)-1-oxoheptan-3-yl]carbamoyl}hexahydrocyclopenta[c]pyrrol-2(1H)-yl]-3,3-dimethyl-1-oxobutan-2-yl}carbamate | | Formula: | C24 H40 F2 N4 O6 | | SMILES: | CNC(=O)C(O)C(CCC(C)(F)F)NC(=O)C1C2CCCC2CN1C(=O)C(NC(=O)OC)C(C)(C)C | | InChi: | InChI=1S/C24H40F2N4O6/c1-23(2,3)18(29-22(35)36-6)21(34)30-12-13-8-7-9-14(13)16(30)19(32)28-15(10-11-24(4,25)26)17(31)20(33)27-5/h13-18,31H,7-12H2,1-6H3,(H,27,33)(H,28,32)(H,29,35)/t13-,14-,15-,16-,17+,18+/m0/s1 | | Definition date: | 2023-11-03 | | Last modified: | 2024-03-01 | | Release date: | 2024-03-06 | | Identifier: | methyl {(2S)-1-[(1S,3aR,6aS)-1-{[(2R,3S)-6,6-difluoro-2-hydroxy-1-(methylamino)-1-oxoheptan-3-yl]carbamoyl}hexahydrocyclopenta[c]pyrrol-2(1H)-yl]-3,3-dimethyl-1-oxobutan-2-yl}carbamate (non-preferred name) |
|
 | | YMC | | Name: | 4-[[4-(3-hydroxyphenyl)phenyl]amino]-1,2-benzoxazol-3-ol | | Formula: | C19 H14 N2 O3 | | SMILES: | Oc1cccc(c1)c2ccc(Nc3cccc4onc(O)c34)cc2 | | InChi: | InChI=1S/C19H14N2O3/c22-15-4-1-3-13(11-15)12-7-9-14(10-8-12)20-16-5-2-6-17-18(16)19(23)21-24-17/h1-11,20,22H,(H,21,23) | | Synonyms: | 4-[(3'-hydroxy[1,1'-biphenyl]-4-yl)amino]-1,2-benzoxazol-3-ol | | Definition date: | 2023-12-05 | | Last modified: | 2024-03-01 | | Release date: | 2024-03-06 | | Identifier: | 4-[[4-(3-hydroxyphenyl)phenyl]amino]-1,2-benzoxazol-3-ol |
|
 | | ZR3 | | Name: | 2-chloro-5-(2-oxoimidazolidin-1-yl)benzoic acid | | Formula: | C10 H9 Cl N2 O3 | | SMILES: | O=C(O)c1cc(ccc1Cl)N1CCNC1=O | | InChi: | InChI=1S/C10H9ClN2O3/c11-8-2-1-6(5-7(8)9(14)15)13-4-3-12-10(13)16/h1-2,5H,3-4H2,(H,12,16)(H,14,15) | | Definition date: | 2023-07-03 | | Last modified: | 2024-03-01 | | Release date: | 2024-03-06 | | Identifier: | 2-chloro-5-(2-oxoimidazolidin-1-yl)benzoic acid |
|
 | | ZR6 | | Name: | 2-methyl-3-(2-oxoimidazolidin-1-yl)benzoic acid | | Formula: | C11 H12 N2 O3 | | SMILES: | O=C(O)c1cccc(c1C)N1CCNC1=O | | InChi: | InChI=1S/C11H12N2O3/c1-7-8(10(14)15)3-2-4-9(7)13-6-5-12-11(13)16/h2-4H,5-6H2,1H3,(H,12,16)(H,14,15) | | Definition date: | 2023-07-03 | | Last modified: | 2024-03-01 | | Release date: | 2024-03-06 | | Identifier: | 2-methyl-3-(2-oxoimidazolidin-1-yl)benzoic acid |
|
 | | VCI | | Name: | ~{N}-[4-[2,6-bis(azanyl)-5-(2-cyclopropylethynyl)pyrimidin-4-yl]phenyl]methanesulfonamide | | Formula: | C16 H17 N5 O2 S | | SMILES: | C[S](=O)(=O)Nc1ccc(cc1)c2nc(N)nc(N)c2C#CC3CC3 | | InChi: | InChI=1S/C16H17N5O2S/c1-24(22,23)21-12-7-5-11(6-8-12)14-13(9-4-10-2-3-10)15(17)20-16(18)19-14/h5-8,10,21H,2-3H2,1H3,(H4,17,18,19,20) | | Definition date: | 2023-03-01 | | Last modified: | 2024-03-01 | | Release date: | 2024-03-06 | | Identifier: | ~{N}-[4-[2,6-bis(azanyl)-5-(2-cyclopropylethynyl)pyrimidin-4-yl]phenyl]methanesulfonamide |
|
 | | ZR9 | | Name: | 2,4-dioxo-1,2,3,4-tetrahydroquinazoline-6-carboxylic acid | | Formula: | C9 H6 N2 O4 | | SMILES: | O=C(O)c1ccc2NC(=O)NC(=O)c2c1 | | InChi: | InChI=1S/C9H6N2O4/c12-7-5-3-4(8(13)14)1-2-6(5)10-9(15)11-7/h1-3H,(H,13,14)(H2,10,11,12,15) | | Definition date: | 2023-07-03 | | Last modified: | 2024-03-01 | | Release date: | 2024-03-06 | | Identifier: | 2,4-dioxo-1,2,3,4-tetrahydroquinazoline-6-carboxylic acid |
|
 | | ZRE | | Name: | 7-fluoro-2-oxo-1,2,3,4-tetrahydroquinoline-6-carboxylic acid | | Formula: | C10 H8 F N O3 | | SMILES: | O=C(O)c1cc2CCC(=O)Nc2cc1F | | InChi: | InChI=1S/C10H8FNO3/c11-7-4-8-5(1-2-9(13)12-8)3-6(7)10(14)15/h3-4H,1-2H2,(H,12,13)(H,14,15) | | Definition date: | 2023-07-03 | | Last modified: | 2024-03-01 | | Release date: | 2024-03-06 | | Identifier: | 7-fluoro-2-oxo-1,2,3,4-tetrahydroquinoline-6-carboxylic acid |
|
 | | Y53 | | Name: | 5-(1~{H}-pyrazol-4-yl)-2-[6-(2,2,6,6-tetramethylpiperidin-4-yl)oxypyridazin-3-yl]phenol | | Formula: | C22 H27 N5 O2 | | SMILES: | CC1(C)CC(CC(C)(C)N1)Oc2ccc(nn2)c3ccc(cc3O)c4c[nH]nc4 | | InChi: | InChI=1S/C22H27N5O2/c1-21(2)10-16(11-22(3,4)27-21)29-20-8-7-18(25-26-20)17-6-5-14(9-19(17)28)15-12-23-24-13-15/h5-9,12-13,16,27-28H,10-11H2,1-4H3,(H,23,24) | | Definition date: | 2023-11-21 | | Last modified: | 2024-03-01 | | Release date: | 2024-03-06 | | Identifier: | 5-(1~{H}-pyrazol-4-yl)-2-[6-(2,2,6,6-tetramethylpiperidin-4-yl)oxypyridazin-3-yl]phenol |
|
 | | ZRZ | | Name: | 3-(6-oxa-9-azaspiro[4.5]decane-9-carbonyl)benzoic acid | | Formula: | C16 H19 N O4 | | SMILES: | O=C(O)c1cccc(c1)C(=O)N1CC2(CCCC2)OCC1 | | InChi: | InChI=1S/C16H19NO4/c18-14(12-4-3-5-13(10-12)15(19)20)17-8-9-21-16(11-17)6-1-2-7-16/h3-5,10H,1-2,6-9,11H2,(H,19,20) | | Definition date: | 2023-07-03 | | Last modified: | 2024-03-01 | | Release date: | 2024-03-06 | | Identifier: | 3-(6-oxa-9-azaspiro[4.5]decane-9-carbonyl)benzoic acid |
|
 | | Y59 | | Name: | 7-(4,7-diazaspiro[2.5]octan-7-yl)-2-(2,8-dimethylimidazo[1,2-b]pyridazin-6-yl)-1~{H}-pyrido[1,2-a]pyrimidin-4-one | | Formula: | C22 H24 N7 O | | SMILES: | Cc1cn2nc(cc(C)c2n1)C3=CC(=O)[n]4cc(ccc4N3)N5CCNC6(CC6)C5 | | InChi: | InChI=1S/C22H24N7O/c1-14-9-18(26-29-11-15(2)24-21(14)29)17-10-20(30)28-12-16(3-4-19(28)25-17)27-8-7-23-22(13-27)5-6-22/h3-4,9-12,23H,5-8,13H2,1-2H3,(H,25,30) | | Definition date: | 2023-11-21 | | Last modified: | 2024-03-01 | | Release date: | 2024-03-06 | | Identifier: | 7-(4,7-diazaspiro[2.5]octan-7-yl)-2-(2,8-dimethylimidazo[1,2-b]pyridazin-6-yl)-1~{H}-pyrido[1,2-a]pyrimidin-4-one |
|
 | | X83 | | Name: | methyl {(2S)-1-[(1S,3aR,6aS)-1-{[(2R,3S,6R)-6-fluoro-2-hydroxy-1-(methylamino)-1-oxoheptan-3-yl]carbamoyl}hexahydrocyclopenta[c]pyrrol-2(1H)-yl]-3,3-dimethyl-1-oxobutan-2-yl}carbamate | | Formula: | C24 H41 F N4 O6 | | SMILES: | CNC(=O)C(O)C(CCC(C)F)NC(=O)C1C2CCCC2CN1C(=O)C(NC(=O)OC)C(C)(C)C | | InChi: | InChI=1S/C24H41FN4O6/c1-13(25)10-11-16(18(30)21(32)26-5)27-20(31)17-15-9-7-8-14(15)12-29(17)22(33)19(24(2,3)4)28-23(34)35-6/h13-19,30H,7-12H2,1-6H3,(H,26,32)(H,27,31)(H,28,34)/t13-,14+,15+,16+,17+,18-,19-/m1/s1 | | Definition date: | 2023-10-24 | | Last modified: | 2024-03-01 | | Release date: | 2024-03-06 | | Identifier: | methyl {(2S)-1-[(1S,3aR,6aS)-1-{[(2R,3S,6R)-6-fluoro-2-hydroxy-1-(methylamino)-1-oxoheptan-3-yl]carbamoyl}hexahydrocyclopenta[c]pyrrol-2(1H)-yl]-3,3-dimethyl-1-oxobutan-2-yl}carbamate (non-preferred name) |
|
 | | ZS5 | | Name: | (3R,4S,7aR)-5-oxo-7a-phenylhexahydropyrrolo[2,1-b][1,3]thiazole-3-carboxylic acid | | Formula: | C13 H13 N O3 S | | SMILES: | O=C(O)C1CSC2(CCC(=O)N12)c1ccccc1 | | InChi: | InChI=1S/C13H13NO3S/c15-11-6-7-13(9-4-2-1-3-5-9)14(11)10(8-18-13)12(16)17/h1-5,10H,6-8H2,(H,16,17)/t10-,13+/m0/s1 | | Definition date: | 2023-07-03 | | Last modified: | 2024-03-01 | | Release date: | 2024-03-06 | | Identifier: | (3R,4S,7aR)-5-oxo-7a-phenylhexahydropyrrolo[2,1-b][1,3]thiazole-3-carboxylic acid |
|
 | | X8F | | Name: | methyl {(2S)-1-[(1S,3aR,6aS)-1-{[(2R,3S,6S)-6-fluoro-2-hydroxy-1-(methylamino)-1-oxoheptan-3-yl]carbamoyl}hexahydrocyclopenta[c]pyrrol-2(1H)-yl]-3,3-dimethyl-1-oxobutan-2-yl}carbamate | | Formula: | C24 H41 F N4 O6 | | SMILES: | CNC(=O)C(O)C(CCC(C)F)NC(=O)C1C2CCCC2CN1C(=O)C(NC(=O)OC)C(C)(C)C | | InChi: | InChI=1S/C24H41FN4O6/c1-13(25)10-11-16(18(30)21(32)26-5)27-20(31)17-15-9-7-8-14(15)12-29(17)22(33)19(24(2,3)4)28-23(34)35-6/h13-19,30H,7-12H2,1-6H3,(H,26,32)(H,27,31)(H,28,34)/t13-,14-,15-,16-,17-,18+,19+/m0/s1 | | Definition date: | 2023-10-24 | | Last modified: | 2024-03-01 | | Release date: | 2024-03-06 | | Identifier: | methyl {(2S)-1-[(1S,3aR,6aS)-1-{[(2R,3S,6S)-6-fluoro-2-hydroxy-1-(methylamino)-1-oxoheptan-3-yl]carbamoyl}hexahydrocyclopenta[c]pyrrol-2(1H)-yl]-3,3-dimethyl-1-oxobutan-2-yl}carbamate (non-preferred name) |
|
 | | VDT | | Name: | 5-(2-cyclopropylethynyl)-6-(2-methoxyphenyl)pyrimidine-2,4-diamine | | Formula: | C16 H16 N4 O | | SMILES: | COc1ccccc1c2nc(N)nc(N)c2C#CC3CC3 | | InChi: | InChI=1S/C16H16N4O/c1-21-13-5-3-2-4-11(13)14-12(9-8-10-6-7-10)15(17)20-16(18)19-14/h2-5,10H,6-7H2,1H3,(H4,17,18,19,20) | | Definition date: | 2023-03-01 | | Last modified: | 2024-03-01 | | Release date: | 2024-03-06 | | Identifier: | 5-(2-cyclopropylethynyl)-6-(2-methoxyphenyl)pyrimidine-2,4-diamine |
|
 | | WSI | | Name: | 2-[[3-[(4-chlorophenyl)carbamoyl]phenyl]sulfonylamino]benzoic acid | | Formula: | C20 H15 Cl N2 O5 S | | SMILES: | OC(=O)c1ccccc1N[S](=O)(=O)c2cccc(c2)C(=O)Nc3ccc(Cl)cc3 | | InChi: | InChI=1S/C20H15ClN2O5S/c21-14-8-10-15(11-9-14)22-19(24)13-4-3-5-16(12-13)29(27,28)23-18-7-2-1-6-17(18)20(25)26/h1-12,23H,(H,22,24)(H,25,26) | | Definition date: | 2023-05-17 | | Last modified: | 2024-03-01 | | Release date: | 2024-03-06 | | Identifier: | 2-[[3-[(4-chlorophenyl)carbamoyl]phenyl]sulfonylamino]benzoic acid |
|
 | | VTX | | Name: | Vortioxetine | | Formula: | C18 H22 N2 S | | SMILES: | Cc1ccc(Sc2ccccc2N3CCNCC3)c(C)c1 | | InChi: | InChI=1S/C18H22N2S/c1-14-7-8-17(15(2)13-14)21-18-6-4-3-5-16(18)20-11-9-19-10-12-20/h3-8,13,19H,9-12H2,1-2H3 | | Synonyms: | 1-[2-(2,4-dimethylphenyl)sulfanylphenyl]piperazine | | Definition date: | 2022-07-27 | | Last modified: | 2024-03-01 | | Release date: | 2024-03-06 | | Identifier: | 1-[2-(2,4-dimethylphenyl)sulfanylphenyl]piperazine |
|
 | | YQT | | Name: | 3-pyridin-4-yl-1~{H}-pyrrolo[3,2-g]isoquinoline | | Formula: | C16 H11 N3 | | SMILES: | [nH]1cc(c2ccncc2)c3cc4ccncc4cc13 | | InChi: | InChI=1S/C16H11N3/c1-4-17-5-2-11(1)15-10-19-16-8-13-9-18-6-3-12(13)7-14(15)16/h1-10,19H | | Definition date: | 2023-12-11 | | Last modified: | 2024-03-01 | | Release date: | 2024-03-06 | | Identifier: | 3-pyridin-4-yl-1~{H}-pyrrolo[3,2-g]isoquinoline |
|
 | | Y9J | | Name: | 2-[[(1~{R},2~{R},3~{a}~{S},9~{a}~{S})-2-oxidanyl-1-[(3~{S})-3-oxidanyloctyl]-2,3,3~{a},4,9,9~{a}-hexahydro-1~{H}-cyclopenta[g]naphthalen-5-yl]oxy]ethanoic acid | | Formula: | C23 H34 O5 | | SMILES: | CCCCC[CH](O)CC[CH]1[CH](O)C[CH]2Cc3c(C[CH]12)cccc3OCC(O)=O | | InChi: | InChI=1S/C23H34O5/c1-2-3-4-7-17(24)9-10-18-19-11-15-6-5-8-22(28-14-23(26)27)20(15)12-16(19)13-21(18)25/h5-6,8,16-19,21,24-25H,2-4,7,9-14H2,1H3,(H,26,27)/t16-,17-,18+,19-,21+/m0/s1 | | Definition date: | 2023-11-28 | | Last modified: | 2024-03-01 | | Release date: | 2024-03-06 | | Identifier: | 2-[[(1~{R},2~{R},3~{a}~{S},9~{a}~{S})-2-oxidanyl-1-[(3~{S})-3-oxidanyloctyl]-2,3,3~{a},4,9,9~{a}-hexahydro-1~{H}-cyclopenta[g]naphthalen-5-yl]oxy]ethanoic acid |
|
